What are the indications for vasopressin and the recommended dosing regimens for refractory septic shock, cardiac arrest, and acute variceal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vasopressin: Indications and Dosing

Vasopressin should be added as a second-line vasopressor at 0.03 units/minute when norepinephrine doses reach 0.25-0.50 µg/kg/min in septic shock, administered at 40 units as a single dose for refractory cardiac arrest, and infused at 1-1.5 units/minute for acute variceal bleeding.

Septic Shock (Refractory)

When to Initiate

Add vasopressin when norepinephrine requirements exceed 0.25-0.50 µg/kg/min despite adequate fluid resuscitation 1. Recent reinforcement learning data suggests earlier initiation may be beneficial—the optimal strategy appears to be starting vasopressin at median norepinephrine doses of 0.20 µg/kg/min rather than waiting for higher doses 2.

Never use vasopressin as monotherapy for septic shock—it must always be combined with norepinephrine 1, 3.

Dosing Regimen

  • Standard dose: 0.03 units/minute (fixed rate, not titrated) 1
  • The FDA label indicates a range of 0.01-0.07 units/minute for septic shock 3
  • Post-cardiotomy shock may require 0.03-0.1 units/minute 3
  • Do not exceed 0.03-0.04 units/minute except as salvage therapy when other vasopressors fail 1

Recent evidence shows no hemodynamic advantage to using 0.04 units/min over 0.03 units/min, so stick with the guideline-recommended 0.03 units/min 4.

Clinical Considerations

Vasopressin works by causing vasoconstriction through V1 receptors and provides a "norepinephrine-sparing effect" 3, 5. Up to one-third of septic shock patients have relative vasopressin deficiency 5.

Factors predicting better response 6:

  • Higher norepinephrine doses (≥0.30 µg/kg/min)
  • Normal BMI (obesity reduces response)
  • Lower lactate levels
  • Higher pH

Factors predicting worse response 6:

  • Obesity (aOR 0.30)
  • Hyperlactatemia (aOR 0.86 per mmol/L increase)
  • Longer duration of norepinephrine before vasopressin initiation

Weaning Strategy

When norepinephrine decreases to approximately 0.2 µg/kg/min, withdraw vasopressin in small steps according to MAP response 7. Rebound hypotension occurs in 9% of patients when vasopressin is terminated, particularly if duration was <24 hours 6.

Cardiac Arrest

Dosing for Refractory Arrest

40 units intravenously as a single dose when initial epinephrine and defibrillation fail 8, 9. This is equivalent to epinephrine 1 mg per current ACLS guidelines 8.

Evidence and Limitations

Vasopressin showed similar outcomes to epinephrine for ventricular fibrillation and pulseless electrical activity, but was superior in asystolic arrest 7. The combination of vasopressin followed by epinephrine resulted in higher rates of survival to hospital admission and discharge 7. However, do not use higher doses or other vasopressors beyond standard-dose epinephrine during CPR 8.

The 2023 AHA guidelines maintain vasopressin as an alternative to epinephrine but do not preferentially recommend it, as no definitive mortality benefit has been established 8.

Acute Variceal Bleeding

Dosing Regimen

High-dose vasopressin: 1-1.5 units/minute by continuous infusion 10. This is substantially higher than septic shock dosing.

Clinical Benefits

High-dose vasopressin for variceal hemorrhage reduces 10:

  • Postoperative mortality (21% vs 6%)
  • Need for emergency operation (40% vs 18%)
  • Operative blood loss (1340 vs 793 mL)

The mechanism involves splanchnic vasoconstriction reducing portal pressure and variceal bleeding 11. Terlipressin (a vasopressin analogue) is also effective and may have fewer cardiac side effects 11.

Important Caveat

While high-dose vasopressin increases adverse effects, no significant morbidity occurred in the landmark study 10. However, this indication requires careful monitoring given the substantially higher doses compared to septic shock.

Critical Warnings

Contraindications 3:

  • Known allergy to vasopressin or chlorobutanol

Common adverse effects 3:

  • Decreased cardiac output
  • Bradycardia and tachyarrhythmias
  • Hyponatremia
  • Ischemia (coronary, mesenteric, skin, digital)
  • Can worsen cardiac function
  • May cause reversible diabetes insipidus
  • Can induce uterine contractions in pregnancy

Drug interactions 3:

  • Additive pressor effects with catecholamines
  • Indomethacin prolongs vasopressin effects
  • Ganglionic blockers increase pressor response
  • Drugs causing diabetes insipidus decrease pressor response

Preparation and Administration

Dilute the 20 units/mL vial with normal saline or D5W to either 0.1 units/mL or 1 unit/mL 3. Discard unused diluted solution after 18 hours at room temperature or 24 hours refrigerated 3. Always use an arterial catheter for blood pressure monitoring when vasopressors are required 1.

References

Research

Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2006

Research

Vasopressin administration in refractory cardiac arrest.

Annals of internal medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.